Delivery Order SPE2DB22D1200-SPE2DB25FN2LY

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,142.61 fixed-price delivery order is for the medical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,523.80 firm fixed-price delivery order is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of November 21, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,994.57 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a performance period through May 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,467.91 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a $4,689.61 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through June 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $18,016.03 firm fixed-price delivery order is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a $1,319.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medical product "ZEPBOUND 15 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 29, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,954.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through April 4, 2025. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,395.96 firm fixed-price delivery order is for the medical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of February 24, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,774.99, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The award has an ultimate completion date of April 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN2LY
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,458.56 firm fixed-price delivery order is for the medical product "ZEPBOUND 15 MG/0.5 ML PEN 0.5ML" and has a completion date of June 11, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/14/25, 1:09 AM